Steatorrhea disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: STT004 MIFTS: 41	Steatorrhea Categories: Gastrointestinal diseases
Genes Tissues Related diseases Publications Pathways Drugs Download Expand all tables

Sources

Aliases & Classifications for Steatorrhea

MalaCards integrated aliases for Steatorrhea:

Name: Steatorrhea ¹² ²⁸ ⁵¹ ⁴¹ ¹⁴

Fatty Stool ¹²

Classifications:

MalaCards categories:
Anatomical: Gastrointestinal diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:10602

MeSH ⁴¹ D045602

NCIt ⁴⁶ C86917

SNOMED-CT ⁶⁴ 197489007 266481005 27868004 more

UMLS ⁶⁹ C0038238

Sources

Summaries for Steatorrhea

MalaCards based summary : Steatorrhea, also known as fatty stool, is related to pancreatic steatorrhea and zollinger-ellison syndrome. An important gene associated with Steatorrhea is PNLIP (Pancreatic Lipase), and among its related pathways/superpathways are Lipoprotein metabolism and Bile secretion. The drugs Pancrelipase and Gastrointestinal Agents have been mentioned in the context of this disorder. Affiliated tissues include testes, bone and colon, and related phenotype is homeostasis/metabolism.

Wikipedia : ⁷² Steatorrhea (or steatorrhoea) is the presence of excess fat in feces. Stools may be bulky and difficult... more...

Sources

Related Diseases for Steatorrhea

Diseases related to Steatorrhea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 120)

#	Related Disease	Score	Top Affiliating Genes
1	pancreatic steatorrhea	32.9	CCK CELA1 PNLIP SCT
2	zollinger-ellison syndrome	30.2	SCT SST
3	cystic fibrosis	29.7	CFTR PNLIP SCT
4	diarrhea	29.7	CCK SST TMPRSS15
5	pancreatic agenesis 1	29.4	CFTR PNLIP SCT
6	exocrine pancreatic insufficiency	29.3	CCK CFTR PNLIP SCT
7	duodenal ulcer	29.3	CCK SCT SST
8	pancreatitis	28.5	APOC2 CCK CFTR PNLIP SCT SST
9	acute pancreatitis	27.8	APOC2 CCK PNLIP SCT SST TMPRSS15
10	celiac disease 1	11.3
11	tropical sprue	11.3
12	blind loop syndrome	11.2
13	glucose intolerance	11.2
14	bile acid malabsorption, primary	11.0
15	bile acid synthesis defect, congenital, 2	10.9
16	bile acid synthesis defect, congenital, 1	10.9
17	hypobetalipoproteinemia, familial, 1	10.9
18	familial lipoprotein lipase deficiency	10.3	APOC2 PNLIP
19	hyperlipoproteinemia, type iv	10.3	APOC2 SLC10A2
20	glucagonoma	10.3	SCT SST
21	hyperinsulinemic hypoglycemia, familial, 2	10.2	SCT SST
22	angiodysplasia	10.2	SCT SST
23	dumping syndrome	10.2	SCT SST
24	biliary dyskinesia	10.2	CCK SCT
25	duodenal disease	10.2	CCK SCT
26	duodenal gastrinoma	10.2	CCK SCT
27	gastrinoma	10.2	SCT SST
28	recurrent acute pancreatitis	10.2	CFTR SCT
29	pancreatic gastrinoma	10.2	SCT SST
30	postcholecystectomy syndrome	10.1	CCK SST
31	bile duct disease	10.1	CCK SLC10A2
32	hypoparathyroidism	10.1
33	biliary tract disease	10.1	CCK SLC10A2
34	secretory diarrhea	10.1	CFTR SST
35	functional gastric disease	10.1	CCK SST
36	rasmussen encephalitis	10.0	CCK SST
37	short bowel syndrome	10.0	CCK SST
38	diabetes mellitus	10.0
39	duodenitis	10.0
40	dyspepsia	10.0	CCK SST
41	fibrosis of extraocular muscles, congenital, 1	10.0
42	stomach disease	9.9	CCK SST
43	chylomicron retention disease	9.9	MTTP SLC10A2
44	duodenogastric reflux	9.9	CCK SCT SST
45	pancreatic cholera	9.9	CCK SCT SST
46	gastrointestinal system disease	9.9	CCK SCT SST
47	megalencephaly	9.9	CCK SST
48	alcoholic pancreatitis	9.9	CCK CFTR SCT
49	lymphoma	9.8
50	cholelithiasis	9.8	CCK SST

Graphical network of the top 20 diseases related to Steatorrhea:

Sources

Symptoms & Phenotypes for Steatorrhea

MGI Mouse Phenotypes related to Steatorrhea:

⁴³

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	homeostasis/metabolism	MP:0005376	9.23	APOC2 CCK CFTR MTTP PNLIP SLC10A2

Sources

Drugs & Therapeutics for Steatorrhea

Drugs for Steatorrhea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Pancrelipase

Approved, Investigational

Phase 4,Phase 3,Phase 2,Phase 1

53608-75-6

Gastrointestinal Agents

Phase 4,Phase 3,Phase 2,Phase 1

pancreatin

Phase 4,Phase 3,Phase 2,Phase 1

Omeprazole

Approved, Investigational, Vet_approved

Phase 3

73590-58-6

4594

Synonyms:

( -)-Omeprazole

(-)-Omeprazole

(S)-(-)-Omeprazole

(S)-Omeprazole

119141-89-8

131959-78-9

172964-80-6

2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole

2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole

2,3,5-Trimethylpyridine/Omeprazole

5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole

5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole

5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole

5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole

6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole

73590-58-6

AC1L1IIJ

AC-401

AGI-010

AKOS005066653

Antra

Antra MUPS

Audazol

Aulcer

AULCER

Axagon

Belmazol

BIDD:GT0189

Bio-0888

BPBio1_000425

BRD-A55962179-001-04-9

BSPBio_000385

C07324

CAS-73590-58-6

CCRIS 7099

Ceprandal

CHEBI:519601

CHEBI:7772

CHEMBL1503

CID4594

CPD000058847

D00455

Danlox

DB00338

DB00736

Demeprazol

Desec

Dizprazol

DM-3458

Dudencer

Elgam

Emeproton

Emilok

Epirazole

Erbolin

esomeprazol

Esomeprazole

Esomperazole

Esopral

Exter

Gasec

Gastrimut

Gastroloc

Gibancer

H 168/68

H 168-68

H168/68

H-168/68

HMS1528I05

HMS1569D07

HMS2052G17

HMS2090E16

HMS2090F11

HSDB 3575

I06-0705

IDI1_032523

Indurgan

Inhibitron

Inhipump

Lensor

Logastric

Lomac

Losec

Losec, Omesec, Prilosec, Zegerid, Omeprazole

LS-7629

Lucen

Maybridge4_002645

Mepral

Miol

Miracid

MLS000069373

MLS001076112

MLS001424148

MolPort-003-666-741

MolPort-003-807-515

MolPort-003-849-702

Mopral

Morecon

NCGC00016925-01

NCGC00016925-02

NCGC00021522-03

NCGC00021522-04

NCGC00021522-05

Nexiam

Nexium

Nexium IV

Nilsec

Nopramin

Nuclosina

O0359

O104_SIGMA

Ocid

Olexin

Olit

Omapren

Omebeta

Omebeta 20

Omed

Omegast

OMEP

Omepradex

Omepral

Omeprazol

Omeprazol [INN-Spanish]

omeprazole

Omeprazole

Omeprazole (JAN/USP/INN)

Omeprazole [USAN:INN:BAN:JAN]

Omeprazole delayed-release

Omeprazole magnesium

Omeprazole Pellets

Omeprazolum

Omeprazolum [INN-Latin]

Omeprazon

Omeprazone

Omeprol

Omesek

Omez

Omezol

Omezolan

Omid

Omisec

Omizac

OMP

Ompanyt

OMZ

Ortanol

Osiren

Ozoken

Paprazol

Parizac

Pepticum

Pepticus

Peptilcer

Prazentol

Prazidec

Prazolit

Prestwick_808

Prestwick0_000493

Prestwick1_000493

Prestwick2_000493

Prestwick3_000493

Prilosec

Prilosec (TN)

Prilosec OTC

Procelac

Proclor

Prysma

Ramezol

Regulacid

Result

S1389_Selleck

SAM001246900

SAN-15

Sanamidol

Secrepina

SMR000058847

SPBio_002306

STK623746

Tedec Ulceral

TL8005099

Ulceral

Ulcesep

Ulcometion

Ulcozol

Ulcsep

Ulsen

Ultop

Ulzol

UNII-KG60484QX9

UPCMLD-DP075

UPCMLD-DP075:001

Victrix

Zefxon

Zegerid

Zepral

Zimor

Zoltum

Antacids

Phase 3

Anti-Ulcer Agents

Phase 3

Proton pump inhibitors

Phase 3

Pharmaceutical Solutions

Phase 2, Phase 3

Pioglitazone

Approved, Investigational

Phase 2

111025-46-8

4829

Synonyms:

(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione

(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione

(+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione

(+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione

105355-27-9

111025-46-8

198077-89-3

2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI)

5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione

5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione

5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione

5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione

5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione

5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione

5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione

AB1004597

AC-1021

AC1L1J1Q

Actos

Actos (TN)

Actost

AD 4833

AD-4833

BRD-A48430263-003-02-4

BSPBio_002723

C07675

C19H20N2O3S

CHEBI:8228

CHEMBL595

CID4829

D08378

DB01132

Duetact

Glustin

HMS2089H14

HS-0047

HSDB 7322

I06-0089

KBio2_002103

KBio2_004671

KBio2_007239

KBio3_001943

KBioGR_001619

KBioSS_002103

LS-151327

MolPort-002-508-211

NCGC00163128-01

NCGC00163128-02

nchembio790-comp10

Pioglitazona

Pioglitazona [INN-Spanish]

Pioglitazone

pioglitazone (INN)

Pioglitazone [Ban:Inn]

Pioglitazone [BAN:INN]

Pioglitazone [INN:BAN]

pioglitazone HCl

Pioglitazone HCl

Pioglitazone Hydrochloride

Pioglitazonum

Pioglitazonum [INN-Latin]

SPBio_001897

Spectrum_001623

Spectrum2_001679

Spectrum3_001002

Spectrum4_001130

Spectrum5_001480

Spectrum5_002067

U 72107

U 72107A

U72,107A

U-72107

UNII-X4OV71U42S

Zactos

Hypoglycemic Agents

Phase 2

insulin

Phase 2

Insulin, Globin Zinc

Phase 2

Menadione

Approved, Nutraceutical

Phase 1

58-27-5

4055

Synonyms:

03AAE1E9-B215-45AF-976C-91E61894A467

1,4-Naphthalenedione, 2-methyl-, radical ion(1-)

2-Methyl-1,4-naftochinon

2-Methyl-1,4-naftochinon [Czech]

2-Methyl-1,4-naphthalendione

2-Methyl-1,4-naphthalenedione

2-Methyl-1,4-Naphthalenedione

2-Methyl-1,4-naphthochinon

2-Methyl-1,4-naphthochinon [German]

2-Methyl-1,4-naphthodione

2-Methyl-1,4-naphthoquinone

2-methyl-1,4-naphthoquinone, 5

2-methylnaphthalene-1,4-dione

2-Methylnaphthoquinone

34524-96-4

3-Methyl-1,4-naphthoquinone

47775_SUPELCO

58-27-5

72060-21-0

AC1L1HBA

AC1Q2HB3

AI3-14700

AKOS004910447

Aquakay

Aquinone

ARONIS24154

BB_NC-2319

BIDD:ER0556

Bio1_000471

Bio1_000960

Bio1_001449

BPBio1_000592

BSPBio_000538

C05377

C11H8O2

CAS-58-27-5

CCRIS 6672

CHEBI:28869

CHEMBL590

CID4055

cMAP_000077

CPD-3766

D02335

DB00170

DivK1c_000080

DivK1c_006287

EINECS 200-372-6

Hemodal

HMS1569K20

HMS1921P06

HMS2092F12

HMS500D22

HSDB 3354

I14-2821

IDI1_000080

InChI=1/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H

Juva-K

Kaergona

Kanone

Kappaxan

Kappaxan (VAN)

Kappaxin

Kappaxin (TN)

Karcon

Kareon

Kativ-G

Kayklot

Kaykot

Kaynone

Kayquinone

KBio1_000080

KBio1_001231

KBio2_001708

KBio2_002527

KBio2_004276

KBio2_005095

KBio2_006844

KBio2_007663

KBio3_003005

KBioGR_000984

KBioGR_002527

KBioSS_001708

KBioSS_002535

Kipca

Kipca, oil soluble

Kipca-Oil Soluble

Klottone

Koaxin

Kolklot

K-Thrombyl

K-Vitan

LS-95653

LS-95654

M0373

M5625_SIGMA

M9429_SIGMA

Memodol

Menadion

menadione

Menadione

Menadione (K3)

Menadione (USP)

Menadione [USAN:BAN]

Menadione semiquinone

Menadionum

Menaphthene

Menaphthon

Menaphthone

Menaphtone

Menaquinone

Menaquinone 0

Menaquinone O

Methyl-1,4-naphthalenedione

Methyl-1,4-naphthoquinone

Methylnaphthoquinone

Mitenon

Mitenone

MLS000069420

MLS001148443

MNQ

MolPort-001-766-699

NCGC00016258-01

NCGC00094978-01

NCGC00094978-02

nchembio.109-comp5

NCI60_003945

NCIMech_000105

NINDS_000080

NSC 4170

NSC4170

Panosine

Prestwick_313

Prestwick0_000459

Prestwick1_000459

Prestwick2_000459

Prestwick3_000459

Prokayvit

QTL1_000056

S1949_Selleck

SMR000059102

SMR000653532

SPBio_001267

SPBio_002477

SpecPlus_000191

Spectrum_001228

SPECTRUM1502254

Spectrum2_001194

Spectrum4_000722

Spectrum5_001764

Synkay

Thyloquinone

UNII-723JX6CXY5

Usaf ek-5185

Vicasol

Vitamin K 3

Vitamin K0

Vitamin K2

Vitamin K2(0)

Vitamin K3

Vitamin K3 : 2-Methyl-1,4-naphthoquinone

Vitamin K3: 1,4-Dihydro-1,4-dioxo-2-methylnaphthalene

Vitamin-?K3

VK3

WLN: L66 BV EVJ C1

ZINC00001677

Phytonadione

Approved, Investigational, Nutraceutical

Phase 1

84-80-0

5284607 4812

Synonyms:

.alpha.-Phylloquinone

1,4-Naphthalenedione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl)-, radical ion(1-)

10485-69-5

11104-38-4

15973-57-6

2-(3,7,11,15-Tetramethylhexadec-2-enyl)-3-methylnaphthalene-1,4-dione

2', 3'-trans-Vitamin K1

2',3'-trans-Vitamin K1

27696-10-2

2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalened- ione

2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione

2-methyl-3-(3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione

2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)-1,4-naphthoquinone

2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone

2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione

2-Methyl-3-phythyl-1,4-naphthochinon

2-Methyl-3-phytyl-1,4-naphthochinon

2-Methyl-3-phytyl-1,4-naphthochinon [German]

2-Methyl-3-phytyl-1,4-naphthoquinone

2-METHYL-3-PHYTYL-14-NAPHTHOQUINONE

3-Phytylmenadione

50926-17-5

84-80-0

AC1NQX34

AC1Q6B3J

alpha-Phylloquinone

Antihemorrhagic vitamin

Aqua mephyton

Aqua-Mephytin

Aquamephyton

AR-1E3503

C02059

C31H46O2

CID5280483

Combinal K1

D00148

DB01022

EINECS 201-564-2

EINECS 234-330-3

EINECS 279-833-9

Fitomenadiona

Fitomenadiona [INN-Spanish]

Fitomenadione

Fitomenadione [DCIT]

HSDB 3162

Kativ N

Kephton

Kinadion

K-Ject

Konakion

LS-94617

LT00452032

Mephyton

Mephyton (TN)

MLS001332659

MLS001332660

MolPort-001-785-978

Monodion

Mono-Kay

NCGC00159423-02

NSC 270681

NSC270681

P0642

Phyllochinon

Phyllochinon [German]

Phyllochinonum

phyllohydroquinone

Phylloquinone

Phylloquinone (8CI)

Phythyl-menadion

Phythyl-menadion (GERMAN)

Phytomenadione

Phytomenadione (INN)

Phytomenadionum

Phytomenadionum [INN-Latin]

phytonadione

Phytonadione (JP15/USP)

Phytonadione [USAN:JAN]

Phytonadionum

Phytylmenadione

SMR000059144

ST075162

Synthex P

trans-Phylloquinone

UNII-A034SE7857

Vitamin k

Vitamin K

VITAMIN K

Vitamin K 1

Vitamin K1

VITAMIN K1

Vitamin K1 (generic)

Vitamin K1 (TN)

Vitamin K1 (VAN)

Vitamin K1(20)

α-phylloquinone

Antifibrinolytic Agents

Phase 1

Coagulants

Phase 1

Hemostatics

Phase 1

Micronutrients

Phase 1

Trace Elements

Phase 1

Vitamins

Phase 1

Menaquinone

Nutraceutical

Phase 1

naphthoquinone

Nutraceutical

Phase 1

Vitamin K

Nutraceutical

Phase 1

Nicotine

Approved

54-11-5

89594 942

Synonyms:

(&#8722

(-)-3-(1-Methyl-2-pyrrolidyl)pyridine

(-)-3-(N-Methylpyrrolidino)pyridine

(−)-nicotine

(-)-Nicotine

(-)-Nicotine solution

(+)-Nicotine

(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine

(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine

(R,S)-Nicotine

(S)-(−)-nicotine

(S)-(-)-Nicotine

(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE

(S)-3-(1-methylpyrrolidin-2-yl)pyridine

(S)-3-(N-methylpyrrolidin-2-yl)pyridine

(S)-Nicotine

)-1-Methyl-2-(3-pyridyl)pyrrolidine

)-Nicotine

)-Nicotine solution

1-Methyl-2-(3-pyridal)-pyrrolidene

1-Methyl-2-(3-pyridal)-Pyrrolidine

1-Methyl-2-(3-pyridiyl)pyrrolidine

1-Methyl-2-(3-pyridyl)pyrrolidine

1uw6

2'-beta-H-Nicotine

3-(1-Methyl-2-pyrollidinyl)pyridine

3-(1-Methyl-2-pyrrolidinyl)pyridine

3-(1-Methyl-2-pyrrolidinyl)-Pyridine

3-(1-Methylpyrrolidin-2-yl)pyridine

3-(2-(N-methylpyrrolidinyl))pyridine

3-(N-methylpyrollidino)pyridine

3-(N-Methylpyrollidino)pyridine

3-(N-Methylpyrrolidino)pyridine

3-[(2S)-1-methylpyrrolidin-2-yl]pyridine

36733_FLUKA

36733_RIEDEL

3-N-Methylpyrrolidine

434F7990-3240-4A43-ACEC-E6CC1E495FA0

46343_FLUKA

46343_RIEDEL

54-11-5

a -N-Methylpyrrolidine

AC1L3I79

AC1Q3ZOC

AI3-03424

alpha-N-Methylpyrrolidine

a-N-Methylpyrrolidine

BB_NC-0777

beta-Pyridyl-alpha-N-methyl pyrrolidine

beta-Pyridyl-alpha-N-methylpyrrolidine

BIDD:GT0599

Black Leaf

Black Leaf 40

bmse000105

BRD-K05395900-322-02-1

C00745

Campbell's Nico-Soap

Caswell No. 597

CCRIS 1637

CHEBI:17688

CHEMBL3

CID89594

Commit

CPD000059074

D03365

delta-Nicotine

Destruxol

Destruxol Orchid Spray

DL-tetrahydronicotyrine

D-Nicotine

EINECS 200-193-3

Emo-Nik

ENT 3,424

EPA Pesticide Chemical Code 056702

Flux Maag

Fumeto bac

Fumetobac

Habitrol

Habitrol (TN)

HSDB 1107

L(-)-nicotine

L(−)-nicotine

L-3-(1-Methyl-2-pyrrolidyl)pyridine

L-Nicotine

LS-202

Mach-Nic

Methyl-2-pyrrolidinyl)pyridine

Micotine

MLS001055457

MLS001335905

MolPort-000-744-731

N3876_SIGMA

N5511_FLUKA

N5511_SIGMA

NCGC00090693-01

NCGC00090693-02

NCGC00090693-03

NCGC00090693-04

NCGC00090693-05

NCGC00090693-06

NCGC00090693-07

NCT

Niagara P.A. Dust

Nicocide

Nicoderm

Nicoderm Cq

Nicoderm Patch

Nico-Dust

Nico-Fume

Nicorette

Nicorette Plus

Nicotin

Nicotina

Nicotina [Italian]

nicotine

Nicotine

Nicotine (compounds related to)

Nicotine (USP)

Nicotine [BSI:ISO]

Nicotine [UN1654]

Nicotine [UN1654] [Poison]

Nicotine [USAN]

Nicotine Alkaloid

NICOTINE AND SALTS

Nicotine betadex

Nicotine Patch

Nicotine polacrilex

Nicotine Polacrilex

nicotine replacement patch

Nicotrol

Nicotrol Inhaler

Nicotrol Ns

Nic-Sal

Nictoine patch

Nikotin

Nikotin [German]

Nikotyna

Nikotyna [Polish]

NSC 5065

NSC97238

Ortho N-4 Dust

Ortho N-5 Dust

PDSP1_000113

PDSP1_000465

PDSP2_000463

PDSP2_000555

Prostep

R)-(+)-Nicotine

RCRA waste no. P075

RCRA waste number P075

SAM002564224

SDCCGMLS-0066911.P001

SMR000059074

Tendust

Transdermal Nicotine

UN1654

Teriparatide

Approved, Investigational

52232-67-4

16133850

Vitamin D

Approved, Nutraceutical, Vet_approved

1406-16-2

Bile Acids and Salts

Antibodies

Immunoglobulins

Cholic Acids

Bone Density Conservation Agents

Calcium, Dietary

glucocorticoids

Interventional clinical trials:

(show all 29)

#	Name	Status	NCT ID	Phase	Drugs
1	Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency	Completed	NCT01327703	Phase 4	Panzytrat® 25,000;Kreon® 25,000
2	Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea	Completed	NCT00572975	Phase 4
3	Enzyme Suppletion in Exocrine Pancreatic Dysfunction	Completed	NCT01430234	Phase 4	Panzytrat 25.000 FIP-E units of Lipase
4	Pancreatic Enzyme Suppletion in Pancreatic Cancer	Withdrawn	NCT01401387	Phase 4
5	Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea	Completed	NCT00559364	Phase 3	Viokase® 16;Placebo;Proton pump inhibitor (PPI);Omeprazole
6	Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)	Completed	NCT00880100	Phase 3	Ultrase® MT12
7	Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis	Completed	NCT00432861	Phase 3	PANCRECARB® (pancrelipase);Placebo
8	Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)	Completed	NCT00408317	Phase 3	Ultrase® MT20;Placebo
9	A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency	Completed	NCT00662675	Phase 3	Pancrease MT 10.5, or MT 21;Placebo for Pancrease MT 10.5 or MT 21
10	Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)	Completed	NCT00513682	Phase 3	Ultrase® MT20
11	Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation	Active, not recruiting	NCT01967888	Phase 2, Phase 3	Reparixin;Placebo
12	Creon in HIV Patients With Steatorrhea	Terminated	NCT00623025	Phase 3	Creon 25000;Placebo
13	Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs	Withdrawn	NCT01228643	Phase 3
14	An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption	Completed	NCT00217204	Phase 2	Pancrelipase microtablets
15	Tolerance and Digestibility of a New Formula in Healthy Infants	Completed	NCT01184378	Phase 2
16	An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)	Completed	NCT00559052	Phase 2	VIOKASE 16
17	Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality	Completed	NCT00782795	Phase 2	Pioglitazone;Placebo
18	A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)	Completed	NCT00676702	Phase 1	Pancrelipase in combination with Ensure Plus
19	Comparison of Feasibility Between Internal and External Pancreatic Drainage in Pancreaticoduodenectomy	Unknown status	NCT01023594
20	Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis	Completed	NCT00006063		pancrelipase with bicarbonate
21	Effect of Potato Fiber on Appetite and Fecal Fat Excretion	Completed	NCT02957318
22	Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic Pancreatitis	Completed	NCT02781987
23	Horton & Maizy Pilot Study for Resistant to Starch	Completed	NCT01338571
24	Timing of Surgical Intervention After Percutaneous Catheter Drainage in STEP UP Approach for Severe Acute Pancreatitis	Completed	NCT01527084
25	The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms"	Completed	NCT02121626
26	Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.	Recruiting	NCT02242123
27	The REPLACE Registry	Recruiting	NCT03115086
28	Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium Disorders	Recruiting	NCT02252679
29	The Natural History of Chronic Pancreatitis	Active, not recruiting	NCT03324698

Search NIH Clinical Center for Steatorrhea

Cochrane evidence based reviews: steatorrhea

Sources

Genetic Tests for Steatorrhea

Genetic tests related to Steatorrhea:

#	Genetic test	Affiliating Genes
1	Steatorrhea ²⁸

Sources

Anatomical Context for Steatorrhea

MalaCards organs/tissues related to Steatorrhea:

³⁸

Testes, Bone, Colon, Pancreatic Islet, Pancreas, Liver, Small Intestine

Sources

Publications for Steatorrhea

Articles related to Steatorrhea:

(show top 50) (show all 314)

#	Title	Authors	Year
1	Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass. ( 28089681 )	Moreland A.M....Fordtran J.S.	2017
2	RE: Steatorrhea, Hyperoxaluria andA Colonic Hyperproliferation After Roux-en-Y Gastric Bypass. ( 28881188 )	Holt P.R.	2017
3	Risk Factors for Steatorrhea in Chronic Pancreatitis: A Cohort of 2,153 Patients. ( 26877248 )	Li B.R....Li Z.S.	2016
4	Dietary green-plant thylakoids decrease gastric emptying and gut transit, promote changes in the gut microbial flora, but does not cause steatorrhea. ( 27777602 )	Stenblom E.L....Montelius C.	2016
5	50 years ago in the journal of pediatrics: disaccharidase deficiencies with steatorrhea. ( 24359902 )	Hill I.D.	2014
6	Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection. ( 23395568 )	Benini L....Frulloni L.	2013
7	Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate. ( 23499748 )	Canales B.K....Hatch M.	2013
8	Education and imaging. Gastrointestinal: "floating oil droplets in the colonic fluid": colonoscopic findings in a patient with pancreatic exocrine insufficiency and steatorrhea. ( 21564288 )	Kim J.W....Kim J.G.	2011
9	Pancreatic lipomatosis with massive steatorrhea. ( 22081194 )	Khan N.A....Islam M.Z.	2011
10	Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? ( 21377551 )	DomA-nguez-MuA+oz J.E.	2011
11	Acid steatocrit determination is not helpful in cystic fibrosis patients without or with mild steatorrhea. ( 20146370 )	Walkowiak J....Radzikowski A.	2010
12	Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis. ( 19034041 )	Chang Y.T....Wong J.M.	2009
13	Treatment of irritable bowel syndrome-diarrhea with pancrealipase or colesevelam and association with steatorrhea. ( 19238028 )	Money M.E....Talley N.J.	2009
14	Spontaneous exocrine pancreas hypoplasia in specific pathogen-free C3HeB/FeJ and 101/H mouse pups causes steatorrhea and runting. ( 17536623 )	Cheeseman M.T....Deeny A.A.	2007
15	An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. ( 16863712 )	Brady M.S....Stevens J.C.	2006
16	Unresponsive or non-compliant steatorrhea in cystic fibrosis? ( 16765107 )	Lisowska A....Walkowiak J.	2006
17	The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. ( 16868481 )	Safdi M....Toskes P.P.	2006
18	Does pancreatic elastase-1 in stools predict steatorrhea in type 1 diabetes? ( 16505538 )	Cavalot F....Trovati M.	2006
19	The incidence, pathogenesis and natural history of steatorrhea after bone marrow transplantation. ( 12728924 )	Grigg A.P....Szer J.	2003
20	High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. ( 14560984 )	Hardt P.D....Kloer H.U.	2003
21	Rethinking growth failure in Alagille syndrome: the role of dietary intake and steatorrhea. ( 12394373 )	Rovner A.J....Zemel B.S.	2002
22	Are minimicrosphere pancrelipase capsules effective enough for the treatment of pancreatic steatorrhea? ( 11374718 )	Chung J.P....Kang J.K.	2001
23	Massive steatorrhea in a child due to isolated pancreatic hypoplasia. ( 11721073 )	Poddar U....Bhasin D.K.	2001
24	Association between steatorrhea, growth, and immunologic status in children with perinatally acquired HIV infection. ( 11177089 )	Sentongo T.A....Mulberg A.E.	2001
25	Positive results on tests for steatorrhea in persons consuming olestra potato chips. ( 10681282 )	Balasekaran R....Fordtran J.S.	2000
26	A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. ( 10950038 )	Stern R.C....Orenstein D.M.	2000
27	Fecal weight determination can unfortunately not replace unpopular and costly fecal fat estimation in the diagnosis of steatorrhea. ( 10211425 )	Lankisch P.G....Lembcke B.	1999
28	Study on pancreatic insufficiency (chronic pancreatitis) and steatorrhea in Japanese patients with low fat intake. ( 10026440 )	Nakamura T....Suda T.	1999
29	Prevalence and significance of steatorrhea in patients with active Graves' disease. ( 9672342 )	Goswami R....Kochupillai N.	1998
30	Esophageal impairment in adult celiac disease with steatorrhea. ( 9707045 )	Iovino P....Mazzacca G.	1998
31	Steatorrhea cannot be excluded where there is a fecal weight below 0.200 kg per day and a high fecal consistency. ( 9890341 )	Thirup P.	1998
32	Determination of fecal fat concentration by near infrared spectrometry for the screening of pancreatic steatorrhea. ( 9520087 )	Ventrucci M....Roda E.	1998
33	Steatorrhea and weight loss in a 72-year-old man: primary biliary cirrhosis? Celiac disease? Bacterial overgrowth? What else? ( 9820402 )	DiBaise J.K....Paustian F.F.	1998
34	Acid steatocrit: a simple, rapid gravimetric method to determine steatorrhea. ( 9399770 )	Amann S.T....Toskes P.P.	1997
35	Can pancreatic steatorrhea be diagnosed without chemical analysis? ( 9387033 )	Nakamura T....Suda T.	1997
36	Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea? ( 9178698 )	Suzuki A....DiMagno E.P.	1997
37	Bone mineral density in patients with pancreatic insufficiency and steatorrhea. ( 9149203 )	MorA!n C.E....Bai J.C.	1997
38	Pancreatic steatorrhea, malabsorption, and nutrition biochemistry: a comparison of Japanese, European, and American patients with chronic pancreatitis. ( 9163777 )	Nakamura T....Takeuchi T.	1997
39	Evaluation of steatorrhea during acute infectious enteritis. ( 8890096 )	Carroccio A....Iacono G.	1996
40	Steatorrhea: a common manifestation in patients with HIV/AIDS. ( 8878143 )	Koch J....Cello J.P.	1996
41	Steatorrhea in Japanese patients with chronic pancreatitis. ( 7719419 )	Nakamura T....Arai Y.	1995
42	Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type I and steatorrhea. ( 7883852 )	Bereket A....Wilson T.A.	1995
43	Steatocrit: a reliable semiquantitative method for detection of steatorrhea. ( 7806830 )	Sugai E....Bai J.C.	1994
44	Fat-soluble vitamin concentration in chronic alcohol-induced pancreatitis. Relationship with steatorrhea. ( 8174441 )	Marotta F....Marks I.N.	1994
45	Octreotide decreases biliary and pancreatic exocrine function, and induces steatorrhea in healthy subjects. ( 7827373 )	Nakamura T....Machida K.	1994
46	New enteric-coated high-lipase pancreatic extract in the treatment of pancreatic steatorrhea. ( 8113582 )	Malesci A....Basilico M.	1994
47	Fecal alpha 1-antitrypsin clearance in the differential diagnosis of steatorrhea. ( 1300854 )	Bai J.C....Mackenzie D.	1992
48	Can diarrhea cause secondary steatorrhea? ( 1587441 )	Newcomer A.D.	1992
49	Fecal fat concentration in the screening of steatorrhea. ( 1289179 )	Benini L....Vantini I.	1992
50	Treatment of severe steatorrhea with ox bile in an ileectomy patient with residual colon. ( 1587199 )	Little K.H....Fordtran J.S.	1992

Sources

Genes for Steatorrhea

Genes related to Steatorrhea (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Implication	PubmedIds
1	PNLIP	Pancreatic Lipase	Protein Coding	42.33	DISEASES inferred ¹⁴ Novoseek inferred ⁵¹ GeneCards inferred via : Publications Summaries (show sections)	15883471 7827373 11276376
2	SCT	Secretin	Protein Coding	32.69	DISEASES inferred ¹⁴ Novoseek inferred ⁵¹ GeneCards inferred via : Publications (show sections)	8208733 9184712 9149203 (more) 17619882 17653788
3	SLC10A2	Solute Carrier Family 10 Member 2	Protein Coding	29.65	DISEASES inferred ¹⁴ Novoseek inferred ⁵¹ GeneCards inferred via : Disorders (show sections)	12819193
4	CELA1	Chymotrypsin Like Elastase Family Member 1	Protein Coding	25.2	DISEASES inferred ¹⁴ GeneCards inferred via : Publications (show sections)
5	SST	Somatostatin	Protein Coding	23.22	DISEASES inferred ¹⁴ Novoseek inferred ⁵¹ GeneCards inferred via : DISEASES inferred (show sections)	9189135 7858282
6	CCK	Cholecystokinin	Protein Coding	22.46	DISEASES inferred ¹⁴ Novoseek inferred ⁵¹ GeneCards inferred via : DISEASES inferred (show sections)	8208733 8159806 9140152
7	TMPRSS15	Transmembrane Protease, Serine 15	Protein Coding	21.42	DISEASES inferred ¹⁴ Novoseek inferred ⁵¹ GeneCards inferred via : DISEASES inferred (show sections)	8208733
8	MTTP	Microsomal Triglyceride Transfer Protein	Protein Coding	21.37	DISEASES inferred ¹⁴ Novoseek inferred ⁵¹ GeneCards inferred via : DISEASES inferred (show sections)	9686820
9	CFTR	Cystic Fibrosis Transmembrane Conductance Regulator	Protein Coding	20.76	DISEASES inferred ¹⁴ Novoseek inferred ⁵¹ GeneCards inferred via : DISEASES inferred (show sections)	15870673 12779072 19808659
10	APOC2	Apolipoprotein C2	Protein Coding	20.66	DISEASES inferred ¹⁴ GeneCards inferred via : Publications (show sections)

Sources

Variations for Steatorrhea

Sources

Expression for Steatorrhea

Search GEO for disease gene expression data for Steatorrhea.

Sources

Pathways for Steatorrhea

Pathways related to Steatorrhea according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Lipoprotein metabolism ⁶² Show member pathways Chylomicron-mediated lipid transport ⁶² Digestion of dietary lipid ⁶² HDL-mediated lipid transport ⁶² Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis ⁶² LDL-mediated lipid transport ⁶² Lipid digestion, mobilization, and transport ⁶² Reelin signalling pathway ⁶² VLDL biosynthesis ⁶² VLDL interactions ⁶² VLDLR internalisation and degradation ⁶²	11.87	APOC2 MTTP PNLIP
2	Bile secretion ³⁶	11.11	CFTR SLC10A2
3	Fat digestion and absorption ³⁶ Show member pathways Trafficking of dietary sterols ⁶²	10.6	MTTP PNLIP
4	Gastric acid production ¹	9.47	CCK SCT

Sources

GO Terms for Steatorrhea

Cellular components related to Steatorrhea according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	extracellular region	GO:0005576	9.43	APOC2 CCK CELA1 PNLIP SCT SST
2	extracellular space	GO:0005615	9.1	APOC2 CCK CELA1 PNLIP SCT SST

Biological processes related to Steatorrhea according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	cholesterol homeostasis	GO:0042632	9.26	APOC2 MTTP
2	retinoid metabolic process	GO:0001523	9.16	APOC2 PNLIP
3	lipoprotein transport	GO:0042953	8.96	APOC2 MTTP
4	chylomicron assembly	GO:0034378	8.62	APOC2 MTTP

Molecular functions related to Steatorrhea according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	hormone activity	GO:0005179	8.8	CCK SCT SST

Sources

Sources for Steatorrhea

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ ExPASy

¹⁷ FDA Approved Drugs

¹⁸ FMA

¹⁹ GeneAnalytics

²⁰ GeneCards

²¹ GeneGo (Thomson Reuters)

²² GeneHancer via GeneCards

²³ GeneReviews

²⁴ Genetics Home Reference

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HGMD

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ MalaCards

³⁹ MedGen

⁴⁰ MedlinePlus

⁴¹ MeSH

⁴² MESH via Orphanet

⁴³ MGI

⁴⁴ NCBI Bookshelf

⁴⁵ NCI

⁴⁶ NCIt

⁴⁷ NDF-RT

⁴⁸ NIH Clinical Center

⁴⁹ NIH Rare Diseases

⁵⁰ NINDS

⁵¹ Novoseek

⁵² Novus Biologicals

⁵³ OMIM

⁵⁴ OMIM via Orphanet

⁵⁵ Orphanet

⁵⁶ PathCards

⁵⁷ PharmGKB

⁵⁸ PubMed

⁵⁹ PubMed Health

⁶⁰ QIAGEN

⁶¹ R&D Systems

⁶² Reactome

⁶³ Sino Biological

⁶⁴ SNOMED-CT

⁶⁵ SNOMED-CT via HPO

⁶⁶ SNOMED-CT via Orphanet

⁶⁷ TGDB

⁶⁸ Tocris

⁶⁹ UMLS

⁷⁰ UMLS via Orphanet

⁷¹ UniProtKB/Swiss-Prot

⁷² Wikipedia